Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials? ; volume:12 ; number:1 ; day:13 ; month:12 ; year:2011 ; pages:1-2 ; date:12.2011
Trials ; 12, Heft 1 (13.12.2011), 1-2, 12.2011
- Creator
-
Ross, Sue
- Contributor
-
Magee, Laura
Wood, Stephen
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-12-S1-A52
- URN
-
urn:nbn:de:1111-2016050223203
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ross, Sue
- Magee, Laura
- Wood, Stephen
- SpringerLink (Online service)
Other Objects (12)
Protecting intellectual property associated with Canadian academic clinical trials - approaches and impact
Sample size calculation in multi-centre clinical trials
Protecting patient privacy when sharing patient-level data from clinical trials
Trials
Nops trials
Noninferiority trials
Imaginary Trials
Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
A systematic review of models to predict recruitment to multicentre clinical trials
Recruiting and retaining medical patients in trials of complex interventions: practical experience of challenges and solutions in three multi-centre trials
Integrating qualitative research in a multi-centre trial - the clinical trials unit perspective
Protecting intellectual property associated with Canadian academic clinical trials - approaches and impact
Sample size calculation in multi-centre clinical trials
Protecting patient privacy when sharing patient-level data from clinical trials
Trials
Nops trials
Noninferiority trials
Imaginary Trials
Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
A systematic review of models to predict recruitment to multicentre clinical trials
Recruiting and retaining medical patients in trials of complex interventions: practical experience of challenges and solutions in three multi-centre trials
Integrating qualitative research in a multi-centre trial - the clinical trials unit perspective
Protecting intellectual property associated with Canadian academic clinical trials - approaches and impact
Sample size calculation in multi-centre clinical trials
Protecting patient privacy when sharing patient-level data from clinical trials
Trials
Nops trials
Noninferiority trials
Imaginary Trials
Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
A systematic review of models to predict recruitment to multicentre clinical trials
Recruiting and retaining medical patients in trials of complex interventions: practical experience of challenges and solutions in three multi-centre trials